IAS Towards an HIV Cure Symposium: people focused, science driven: 18-19 July 2015, Vancouver, Canada.

• Type of Material: Conference Paper
• Authors: Sarah Fidler, Imperial College London; John Thornhill, Imperial College London; Eva Malatinkova, Ghent University and Ghent University Hospital; Robert Reinhard, University of Toronto; Rosanne Lamplough, International AIDS Society; Jintanat Ananworanich, The Henry M. Jackson Foundation for the Advancement of Military Medicine; Ann Chahroudi, Emory University
• Language: English
• Date: 2015-10-01
• Publisher: Emory University Libraries
• Publication Version: Final Published Version
• Copyright Statement: © 2015 The Authors
• License: Creative Commons Attribution 4.0 International
• Final Published Version (URL): http://viruseradication.com/journal-details/IAS_Towards_an_HIV_Cure_Symposium:_people_focused,_science_driven_18%E2%80%9319_July_2015,_Vancouver,_Canada/
• Title of Journal or Parent Work: Journal of Virus Eradication
• Conference or Event Name: Towards an HIV Cure Symposium
• Volume: 1
• Issue: 4
• Start Page: 276
• End Page: 281
• Grant/Funding Information: The IAS 2015 Towards an HIV Cure Symposium was supported by the National Institutes of Health, Office of AIDS Research (NIH-OAR), the French National Agency for Research on AIDS and Viral Hepatitis (ANRS), the Canadian Institutes of Health Research (CIHR), Bristol-Myers Squibb, Gilead, GlaxoSmithKline, ViiV Healthcare, MSD, Sanofi Aventis, Sanofi Pasteur, the Réseau SIDA/MI du FRSQ and Sidaction.
• Research Categories: Health Sciences, Epidemiology; Health Sciences, Pathology; Health Sciences, Public Health

Abstract

The International AIDS Society (IAS) convened the Towards an HIV Cure Symposium on 18-19 July 2015 in Vancouver, Canada, bringing together researchers and community to discuss the most recent advances in our understanding of HIV latency, reservoirs and a summary of the current clinical approaches towards an HIV cure. The symposium objectives were to: (1) gather researchers and stakeholders to present, review, and discuss the latest research towards an HIV cure; (2) promote cross-disciplinary global interactions between basic, clinical and social scientists; and (3) provide a platform for sharing information among scientists, clinicians, funders, media and civil society. The symposium examined basic molecular science and animal model data, and emerging and ongoing clinical trial results to prioritise strategies and determine the viral and immune responses that could lead to HIV remission without antiretroviral therapy. This report summarises some of the major findings discussed during the symposium.